Evaluation of acute and chronic nephrotoxicity in patients received cisplatin-based chemotherapy: has anything changed over time?
Authors:
- 14 August 2021
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 54 (5) , 1085-1090
Abstract
Purpose The aim of this study was to determine the frequency and the risk factors of acute and chronic nephrotoxicity in patients who received cisplatin due to malignancy. Materials and methods Medical records of all patients who received cisplatin-based chemotherapy regimen between January 2013 and July 2019 were retrospectively evaluated. The data of 203 patients who met the study criteria were examined. The patients were evaluated for acute nephrotoxicity at 48 h and late nephrotoxicity at 3rd month after first course of cisplatin. Early and late nephrotoxicity were defined by NCI CTCAE Version 4.0 criteria. Results The mean age of the study patients was 56.44 ± 12.69 years, 78.8% were males and 21.2% were females. It is revealed that the incidence of cisplatin-induced acute nephrotoxicity was 9.2% and chronic nephrotoxicity was 37.9%. While the development of acute nephrotoxicity was associated with female gender, history of diabetes mellitus, history of ischemic heart disease and use of antiplatelet drug, the development of chronic nephrotoxicity was associated with older age, female gender and using of diuretics. High serum creatinine, urea and low eGFR value before treatment were found to be associated with both early and late nephrotoxicity (p < 0.05). There was no statistically significant relationship between acute or chronic nephrotoxicity and cumulative dose of cisplatin, hydration or intravenous magnesium supplementation. Conclusion High initial serum creatinine value and low initial eGFR are the most important determinants of both early and late nephrotoxicity.Keywords
This publication has 20 references indexed in Scilit:
- Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and RadiotherapyAmerican Journal of Clinical Oncology, 2018
- Long–Term Renal Outcomes after Cisplatin TreatmentClinical Journal of the American Society of Nephrology, 2016
- Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort StudyPLOS ONE, 2015
- Aging increases the susceptibility of cisplatin-induced nephrotoxicityAGE, 2015
- The Risk Factors of Severe Acute Kidney Injury Induced by CisplatinOncology, 2013
- Acute Kidney Injury in the ElderlyClinics in Geriatric Medicine, 2013
- Acute Kidney Injury Episodes and Chronic Kidney Disease Risk in Diabetes MellitusClinical Journal of the American Society of Nephrology, 2011
- Inborn Nephron Diversity and Its Clinical ConsequencesRambam Maimonides Medical Journal, 2011
- The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill PatientsClinical Pharmacokinetics, 2011
- Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: A randomised phase II studyEuropean Journal of Cancer, 2008